Xingmeng Biopharmaceuticals (Suzhou) Co., Ltd. was established in August of 2016 through the merge and relocation of two of its primary entities: Xingmeng Biotechnology (Beijing) Co., Ltd., which was initially a process research and development center, and Shenzhen Longrui Pharmaceutical Co., Ltd., which served as the original pilot production facility. The company is strategically situated in Phase II of the BioBay of the Suzhou Industrial Park, serving as the operational headquarters in China. Xingmeng is dedicated to the R&D and manufacturing of innovative monoclonal antibody drugs and biosimilars, targeting the treatment of malignant tumors, allergic ailments, infectious diseases, and autoimmune disorders.

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Monoclonal antibody	1

Top 5 Target	Count

EGFR(Epidermal growth factor receptor erbB1)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

Current Projects

Drug(Targets)	Indications	Global Highest Phase

LR-004(Lonn Ryonn Pharma Ltd) ( EGFR )	Metastatic Colorectal Carcinoma More	Phase 1

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis